Cho; Byoung Chul

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cho; Byoung Chul.The latest application filed is for "benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer".

Company Profile

5.8.11

Cho; Byoung Chul - Seoul KR
Cho; Byoung Chul - Daejeon KR
Cho; Byoung-Chul - Seongnam-si KR
Cho; Byoung Chul - Anyang-si KR
Cho; Byoung-Chul - Bucheon KR
Cho; Byoung-Chul - Bucheon-city KR
Cho; Byoung-chul - Gwangju Metropolitan KR
Cho, Byoung-chul - Gwangju Metropolitan City KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Benzamide Derivative, Preparation Method Therefor, And Pharmaceutical Composition Comprising Same As Active Ingredient For Prevention Or Treatment Of Cancer App 20220281817 - Lee; Kwangho ; et al.	2022-09-08
N2,n4-diphenylpyrimidine-2,4-diamine Derivative, Method For Preparing Same, And Pharmaceutical Composition Containing Same As Active Ingredient For Prevention Or Treatment Of Cancer App 20220249482 - Lee; Kwangho ; et al.	2022-08-11
N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer Grant 11,253,516 - Lee , et al. February 22, 2	2022-02-22
Isoindolin-1-on Derivative, Method For Preparing Same, And Pharmaceutical Composition Comprising Same As Effective Component For Preventing Or Treating Cancer App 20210332029 - Lee; Kwangho ; et al.	2021-10-28
Method For Enhancing Immune Function Of Immune Cell And Immune Cell Line Produced Using The Same App 20210292710 - CHO; Byoung Chul ; et al.	2021-09-23
Round chip scale package and manufacturing method therefor Grant 10,950,762 - Min , et al. March 16, 2	2021-03-16
Use of statin-based drug for treatment of EML4-ALK-positive non-small cell lung cancer progressing on ALK inhibitor Grant 10,688,085 - Cho , et al.	2020-06-23
N2,n4-diphenylpyrimidine-2,4-diamine Derivative, Method For Preparing Same, And Pharmaceutical Composition Containing Same As Ac App 20200179384 - Lee; Kwangho ; et al.	2020-06-11
Use of EI24 gene Grant 10,480,032 - Lee , et al. Nov	2019-11-19
Use Of Statin-based Drug For Treatment Of Eml4-alk-positive Non-small Cell Lung Cancer Resistant To Alk Inhibitor App 20190046514 - CHO; Kyoung-Je ; et al.	2019-02-14
Mucosal dose control radiotherapy apparatus using magnetic fields Grant 10,080,912 - Kwak , et al. September 25, 2	2018-09-25
Novel Use Of Ei24 Gene App 20170268067 - LEE; Han Woong ; et al.	2017-09-21
Mucosal Dose Control Radiotherapy Apparatus Using Magnetic Fields App 20160175616 - Kwak; Jung Won ; et al.	2016-06-23
3-phase inverter module, motor driving apparatus using the same, and inverter integrated circuit package Grant 8,027,183 - Cho , et al. September 27, 2	2011-09-27
Power module for energy recovery and discharge sustain of plasma display panel Grant 7,859,528 - Cho , et al. December 28, 2	2010-12-28
3-Phase inverter module, motor driving apparatus using the same, and inverter integrated circuit package App 20080002445 - Cho; Byoung-Chul ; et al.	2008-01-03
Power module for energy recovery and discharge sustain of plasma display panel App 20070285024 - Cho; Byoung-Chul ; et al.	2007-12-13
Inverter circuit having switching device with gate driven by high-voltage integrated circuit Grant 7,095,639 - Cho , et al. August 22, 2	2006-08-22
Inverter circuit having switching device with gate driven by high-voltage integrated circuit App 20040190317 - Cho, Byoung-chul ; et al.	2004-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.